| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $21.9B | $19.7B | $19.0B | $19.6B | $16.8B | $14.9B | $3.6B | $3.8B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $5.3B | $4.3B | $3.6B | $3.5B | $3.4B | $3.0B | $0.3B | $0.6B |
| Net Income | $3.7B | $3.0B | $2.2B | $2.3B | $2.5B | $2.2B | $0.2B | $0.4B |
| EPS (Basic) | $6.70 | $5.60 | $4.26 | $4.51 | $4.97 | $4.44 | $3.89 | $3.90 |
| EPS (Diluted) | $6.66 | $5.58 | $4.24 | $4.49 | $4.96 | $4.42 | $3.88 | $3.90 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $114.5B | $103.1B | $96.7B | $93.5B | $87.7B | $80.8B | $75.9B | $68.8B |
| Current Assets | $6.1B | $5.8B | $6.1B | $9.4B | $7.8B | $4.4B | $4.1B | $4.1B |
| Cash & Equivalents | $0.2B | $0.2B | $0.3B | $0.5B | $0.4B | $0.4B | $0.2B | $0.2B |
| Total Liabilities | $82.2B | $76.1B | $71.4B | $69.3B | $64.9B | $59.9B | $55.9B | $49.6B |
| Current Liabilities | $13.3B | $13.0B | $11.6B | $14.6B | $12.4B | $9.9B | $10.3B | $8.6B |
| Stockholders' Equity | $31.1B | $26.9B | $25.2B | $23.9B | $22.4B | $20.6B | $19.6B | $19.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $6.9B | $6.8B | $5.0B | $5.3B | $3.8B | $3.8B | $4.3B | — |
| Investing Cash Flow | $-11.9B | $-7.6B | $-6.3B | $-7.8B | $-6.4B | $-6.2B | $-7.1B | — |
| Capital Expenditures | — | — | — | — | — | $0.0B | $0.9B | $0.0B |
| Financing Cash Flow | $5.0B | $0.7B | $1.1B | $2.6B | $2.6B | $2.4B | $2.9B | — |